Health Care Policy

To read an article click on the image. Click again to see the published work:

Is There A Better Place To Decide What’s Right For Patients?

In Bold Move, FDA Approves Cancer Drug For Any Advanced Tumor With Genetic Changes

Before Breast Cancer Surgery, A Question Every Patient Should Ask Her Surgeon

We Need To Tame The Price Of New Cancer Drugs

Team Care Slashes Deaths From Pregnancy In Sickle Cell Anemia

How The 21st Century Cures Act Should Support Public Health

Why Patients Support The 21st Century Cures Act

The FDA Did The Right Thing By Approving a Novel Drug For A Disabling Disease

A Modern, Adaptive FDA Should Support Patients’ Right To Try New Medications

Lip Service To Patients And Caregivers, Or Respect? The Significance Of An FDA Panel’s Review

Five Key Issues For The Future Of Cancer IT

Why Many Cancer Drugs Don’t Have To Cost So Much

Flint’s Lead-Contaminated Water Points To Health Effects Of Ailing Infrastructure

Patients Shouldn’t Be Used As Hostages, Vulnerable To Sudden Drug Price Increases

Precision Medicine Will (Eventually) Lower Cancer Care Costs

Why Women And Doctors Need To Know More About DCIS

Bill Branson (Photographer) - This image was released by the National Cancer Institute, an agency part of the National Institutes of Health, with the ID 2538 (image) (next).

Logistic Toxicity, An Unmeasured Burden Of Healthcare

How To Avoid Overdiagnosis And Overtreatment Of Breast Cancer

SCOTUS Saves Obamacare, But More Change Is Needed

Study Highlights Social Factors Affecting Breast Cancer Surgery

Cutting Through The Hyped Costs Of Mammograms

Understanding Angelina Jolie Pitt’s Cancer Risk And Her Decision To Tell About It

Recent Studies Of Mammography Use Shockingly Old Data

’60 Minutes’ Is Right To Raise Questions About Lumber Liquidators’ Toxic Floors

All Women Should Have Access To Ultrasound Screening For Breast Cancer

Mandatory Reporting Of Breast Density In Screening Mammograms. Why The Controversy?

Can The Mammogram Panel Read A Mammogram?

Why The FDA Panel’s Nod To Sandoz’s Filgrastim (Zarzio) Is Good News For Patients

Why Yes, We Should Treat Cancer

A Gift? Health Care Without The Business

So What About That Acrylamide In Your French Fries?

Collateral Damage: How A Cancer Diagnosis Hurts Employment And Finances